Earnings
Brookfield posts earnings miss, revenue beats forecasts
Asset manager's adjusted profit fell short of expectations by $0.51 per share, though total revenue exceeded analyst projections.
American Shared Hospital Services posts EPS miss, revenue beats
Quarterly earnings per share fell short of expectations while total revenue exceeded analyst forecasts.
Brookfield Q2 earnings miss estimates, shares slip
Brookfield’s second-quarter profit fell short of analyst forecasts, sending shares modestly lower in early trading.
Stratasys posts earnings beat but revenue misses forecasts
3D printing firm Stratasys reported adjusted profit above expectations but revenue fell short of analyst projections in the latest quarter.
Cellebrite earnings beat estimates, revenue misses forecast
Digital forensics firm posts adjusted profit above expectations but revenue falls short of analyst projections amid market volatility.
Apollo Hospitals Q1 2026 profit beats estimates on strong growth
India's largest hospital operator reported quarterly earnings above market expectations, driven by higher patient volumes and expanded services.
JD Health posts strong H1 2024 profit growth in earnings call
Chinese healthcare platform JD Health reports robust first-half profit growth, driven by core retail and online pharmacy segments, according to its latest earnings call transcript.
Netcompany lifts 2026 outlook after Q2 results
Danish IT services firm upgrades annual revenue guidance for 2026 following stronger-than-expected second-quarter results.
Trend Micro Q2 2026 sales rise but profit declines
Cybersecurity firm reports higher revenue offset by increased costs, with net income falling short of analyst expectations.
Samsung Life posts strong H1 profit; shares slip on volatility
South Korea's largest life insurer reported robust first-half earnings but saw shares dip amid broader market volatility. Analysts cite macro uncertainty as key pressure point.
SpareBank 1 Sør-Norge posts Q2 2026 profit beat, shares rise
Norwegian regional lender SpareBank 1 Sør-Norge reported stronger-than-expected second-quarter 2026 profit, lifting shares amid improved net interest margins and lower credit losses.
CEWE Group posts solid H1 2026 earnings, shares dip
German photo service provider reports growth in first half of 2026 but faces investor skepticism amid broader sector challenges.
Walmart shares seen swinging up to 4.6% on earnings
Options market signals potential volatility ahead of Walmart’s Aug. 20 earnings release, with implied moves of 4.6% in either direction.
Wolverine reports Q2 earnings beat, revenue above forecast
Footwear and apparel company Wolverine posts adjusted EPS of $0.68, beating estimates by $0.02, while revenue rises 8% year-over-year to $720 million.
SBC Medical Holdings earnings miss estimates by $0.02
Revenue exceeded forecasts as the healthcare firm posted adjusted profit below analyst expectations.
Applied Industrial Technologies tops earnings, revenue estimates
Industrial distributor posts adjusted EPS of $2.45, beating expectations by $0.25, with revenue rising 7% year-over-year.
Wolverine World Wide jumps 8% premarket on Q2 beat, raised outlook
Footwear maker Wolverine World Wide reported better-than-expected second-quarter results and raised its full-year guidance, sending shares up 8% in premarket trading.
Dillard's Q2 profit beats estimates, revenue misses
Retailer posts adjusted EPS of $11.86 vs. $9.93 forecast as sales fall short of projections.
Applied Industrial Technologies Q4 earnings beat lifts shares 4%
Industrial distributor reports stronger-than-expected Q4 results amid robust demand, shares rise after earnings release.
MediPharm Labs posts first profit since 2019 in Q2 2026
Canadian cannabis producer MediPharm Labs reported its first quarterly profit in seven years, driven by improved margins and cost controls in Q2 2026.
Gap Inc. Q2 2026 profit beats forecast, sales fall short
Gap Inc. reported adjusted earnings per share above expectations for Q2 2026, though net sales declined marginally year-over-year.
PROREIT Q2 2026 revenue beats estimates, funds from operations rise
Canadian real estate investment trust reports second-quarter revenue of C$32.4 million, topping analyst forecasts, while funds from operations climb 4.2% year-over-year.
Valneva H1 2026 loss widens as Lyme vaccine development advances
Biotech firm Valneva reports widening net loss in first half of 2026 despite progress on its Lyme disease vaccine candidate. Shares dip on earnings call.
Nuwellis reports higher Q2 2026 revenue as loss narrows
Medical device maker Nuwellis posted revenue growth in its second quarter of 2026, with a reduced net loss compared to the prior-year period.